NASDAQ: CAMP
Camp4 Therapeutics Corp Stock

$1.48-0.03 (-1.99%)
Updated Aug 28, 2025
CAMP Price
$1.48
Fair Value Price
$2.77
Market Cap
$29.84M
52 Week Low
$1.31
52 Week High
$12.30
P/E
0.04x
P/B
0.75x
P/S
9.72x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.01M
Earnings
-$51.78M
Gross Margin
100%
Operating Margin
-1,722.08%
Profit Margin
-1,722.1%
Debt to Equity
0.28
Operating Cash Flow
-$46M
Beta
1.23
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CAMP Overview

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CAMP's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
CAMP
Ranked
Unranked of 483

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important CAMP news, forecast changes, insider trades & much more!

CAMP News

Overview

Due Diligence Score

Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CAMP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CAMP ($1.48) is undervalued by 46.49% relative to our estimate of its Fair Value price of $2.77 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CAMP ($1.48) is significantly undervalued by 46.49% relative to our estimate of its Fair Value price of $2.77 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CAMP is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
There are 30 more CAMP due diligence checks available for Premium users.

Valuation

CAMP fair value

Fair Value of CAMP stock based on Discounted Cash Flow (DCF)

Price
$1.48
Fair Value
$2.77
Undervalued by
46.49%
CAMP ($1.48) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CAMP ($1.48) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

CAMP price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0.04x
Industry
-101.77x
Market
35.78x
CAMP is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CAMP is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CAMP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.75x
Industry
4.56x
CAMP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CAMP's financial health

Profit margin

Revenue
$1.5M
Net Income
-$12.6M
Profit Margin
-840.8%
CAMP's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CAMP's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$51.3M
Liabilities
$11.3M
Debt to equity
0.28
CAMP's short-term assets ($41.09M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CAMP's short-term assets ($41.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CAMP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$10.3M
Investing
$0.0
Financing
$72.0k
CAMP's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CAMP vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CAMP$29.84M-1.99%0.04x0.75x
ANTX$30.06M-3.51%-0.89x0.44x
CLSD$30.07M0.00%-0.94x-0.66x
KZR$29.07M+0.25%-0.41x0.32x
ITRMD$30.90M-4.16%-0.85x-7.95x

Camp4 Therapeutics Stock FAQ

What is Camp4 Therapeutics's quote symbol?

(NASDAQ: CAMP) Camp4 Therapeutics trades on the NASDAQ under the ticker symbol CAMP. Camp4 Therapeutics stock quotes can also be displayed as NASDAQ: CAMP.

If you're new to stock investing, here's how to buy Camp4 Therapeutics stock.

What is the 52 week high and low for Camp4 Therapeutics (NASDAQ: CAMP)?

(NASDAQ: CAMP) Camp4 Therapeutics's 52-week high was $12.30, and its 52-week low was $1.31. It is currently -87.97% from its 52-week high and 13.41% from its 52-week low.

How much is Camp4 Therapeutics's stock price per share?

(NASDAQ: CAMP) Camp4 Therapeutics stock price per share is $1.48 today (as of Aug 28, 2025).

What is Camp4 Therapeutics's Market Cap?

(NASDAQ: CAMP) Camp4 Therapeutics's market cap is $29.84M, as of Aug 29, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Camp4 Therapeutics's market cap is calculated by multiplying CAMP's current stock price of $1.48 by CAMP's total outstanding shares of 20,161,073.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.